Target intelligence / Profile preview

RNA, Ro-associated Y4 pseudogene 16 (RNY4P16)

Target: RNY4P16
Molecular classification: Other (pseudogene), Non-coding RNA

Overview

RNY4 pseudogene 16 (RNY4P16) is a pseudogenic copy of the RNY4 gene, annotated as a non-coding RNA on chromosome 1[4]. Unlike the parent RNY4 gene, which is a member of the Y RNA family implicated in DNA replication, RNA stability, and potential biomarker roles in cancer, the pseudogene RNY4P16 is not believed to encode a functional RNA nor is it implicated in any known biological processes or disease phenotypes[4]. There is currently no evidence that RNY4P16 is a receptor, enzyme, or therapeutic target, nor that it directly influences cellular function or disease.

Other names: RNY4 pseudogene 16RNA, Ro-associated Y4 pseudogene 16RNY4P16

Beyond the preview

Go deeper on RNA, Ro-associated Y4 pseudogene 16 (RNY4P16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, Ro-associated Y4 pseudogene 16 (RNY4P16).

Explore the full profile